|
End-of-day quote
Korea S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 201,000.00 KRW | -0.50% |
|
+0.85% | +16.60% |
| 08-04 | Celltrion Files Phase 3 Trial Amendment for CT-P44 Biosimilar for Myeloma | MT |
| 07-24 | Celltrion Submits EMA Marketing Authorization Application for Cosentyx Biosimilar CT-P55 | MT |
Transcripts
Search
| 24-11-27 | Celltrion, Inc. - Analyst/Investor Day | |
| 17-01-04 | Celltrion Provides Earnings Guidance for the Year 2017 | CI |
No results match your criteria
- Stock Market
- Stocks
- A068270 Stock
- News Celltrion, Inc.
- Transcripts
Select your edition
All financial news and data tailored to specific country editions
